Chemoimmunotherapy Tied to Better Outcomes in Advanced NSCLC

(MedPage Today) -- Patients with advanced non-small cell lung cancer (NSCLC) and PD-L1 scores 1%-49% who received chemoimmunotherapy regimens seemed to do better than patients treated with immunotherapy alone, according to an exploratory pooled...